Apr 14, 2022 / 07:30AM GMT
Operator
Hello, and welcome to the Fagron trading update Q1 2022. Please note, this conference is being recorded. (Operator Instructions) I will now hand over to your host, Karen Berg, to begin today's conference. Thank you.
Karen Berg - Fagron NV - Global IR Manager
Thank you, and Good morning, everyone. Welcome to the presentation of our first quarter 2022 trading update. I'm here together with our CEO, Rafael Padilla; and our CFO, Karin de Jong. Rafael will start with a discussion of the business development, and then Karin will discuss the financial development, and then we will open the line for questions. Well, thank you for that. And I would like to hand over to Rafael.
Rafael Padilla - Fagron NV - CEO & Executive Director
Thank you very much, Karen, and thank you all for joining us into this Q1 conference call. We start always with our purpose as we are a culture-driven company. Together, we create the future of personalizing medicine. Personalizing medicine is the future. And pharmaceutical compounding mix is
Q1 2022 Fagron NV Trading Statement Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot